This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Sanofi. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Alain Krick: Innovator in Anti-Cancer Compounds
Introduction
Alain Krick is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-cancer compounds. With a total of 2 patents, his work is paving the way for new treatments in oncology.
Latest Patents
Krick's latest patents focus on an anti-cancer compound and pharmaceutical composition. The invention relates to a compound of formula (I), specifically in the levorotatory form (1a). This form has a rotatory power [α]D=−38.6+0.7 at a concentration of 0.698 mg/ml in methanol. The compound can exist as a base or an acid addition salt, particularly a pharmaceutically acceptable acid. It serves as a selective Aurora A and B kinase inhibitor, making it a promising candidate for anticancer drug development.
Career Highlights
Alain Krick is currently associated with Sanofi, a leading global healthcare company. His work at Sanofi has allowed him to focus on innovative solutions in the pharmaceutical industry. His contributions are vital in the ongoing fight against cancer.
Collaborations
Krick collaborates with esteemed colleagues such as Jean-Christophe Carry and Michel Cheve. Their combined expertise enhances the research and development efforts within their projects.
Conclusion
Alain Krick's innovative work in anti-cancer compounds exemplifies the critical role of inventors in advancing medical science. His patents and collaborations contribute significantly to the development of effective cancer treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile